Ansell (PD1A) Q4 2026 Earnings Report
DE:PD1A Q4 2026 EPS Results
- Actual EPS
- EUR 0.73
- Consensus EPS
- EUR 0.69
- Beat/Miss
- Beat by +EUR 0.04
- One Year Ago EPS
- EUR 0.63
DE:PD1A Q4 2026 Revenue Results
- Actual Revenue
- EUR 986.93M
- Expected Revenue
- EUR 931.07M
- Beat/Miss
- Beat by +EUR 55.86M
- YoY Revenue Growth
- +2.23%
Earnings Announcement Details
- Quarter
- Q4 2026
- Date
- 08/23/2026
- Time
- After Close
- Conference Call
- Sunday, August 23, 2026
Ansell's next earnings date is estimated for February 22, 2027, based on past reporting schedules.
Q4 2026 Earnings Call Audio
Q4 2026 Earnings Slide Deck
Q4 2026 Earnings Call Summary
The call presented a clear majority of positive operational and financial outcomes — double-digit EPS growth, higher margins, strong cash conversion, U.S. and Cleanroom-led sales momentum, recurring cost savings (APIP $50M) and improved balance sheet metrics. Management also acknowledged and proactively managed notable headwinds (Middle East cost inflation, U.S. tariffs, commodity volatility, FX hedge losses and non‑cash impairments), and provided a constructive FY'27 EPS guidance range of $1.58–$1.70 with assumptions of continued volume/price momentum and ~$9M FX tailwind. On balance the positives — strong execution, margin expansion, cash generation and concrete operational improvements — outweigh the transient and manageable risks cited.
Ansell guided adjusted EPS of $1.58–$1.70 for FY27 (FY26 adjusted EPS $1.486), implying ~6.4%–14.4% upside (midpoint ~$1.64, ≈10.3% growth), on assumptions of continued sales momentum from both volume and pricing, focus on higher‑margin markets/brands and ongoing commercial and operational excellence; management also factored in a $9m FX benefit versus FY25. They expect GPADE and margin improvement from mix and productivity, SG&A to be managed around prior‑year growth (~2.7%), lower net capex than FY26 ($48.6m) with targeted strategic investment, continuation of the on‑market buyback program, and a conservative funding profile (net debt/EBITDA target 1.5–2.5x, currently 1.3x) with $752m of cash and undrawn facilities — while noting macro uncertainty.
- Top-line growth and second-half momentumAdjusted net sales grew 5.7% for FY'26 (ex-FX and product exits). Second-half growth accelerated to 9.2%, driven by improving volume trends.
- Strong performance in U.S. and strategic segmentsU.S. (43% of sales) grew ~10% and outpaced the company (U.S. grew ~1.8x faster). Cleanroom/scientific business grew 10% for the full year; Healthcare second-half growth was 12.3%.
- Profitability expansionAdjusted EBIT margin improved to 15%, up 90 basis points year-on-year. GPADE margin increased by 70 basis points versus FY'25.
- Segment margin improvementsHealthcare delivered a notable step-up in EBIT margin from 12.8% to 14.3% (≈150 bps improvement). Industrial margins also improved (management cited an increase to ~18% from ~17.3%).
- EPS, dividends and capital returnsAdjusted EPS was $1.486, up 18.5% year-on-year. Full-year dividend increased 35.7% to $0.681. On‑market share buybacks totaled $118.4M in FY'26.
- Very strong cash generation and balance sheetCash conversion improved to 113% (from 91% prior year). Net CapEx reduced to $48.6M. Net debt/EBITDA improved to 1.3x (from 1.6x) and liquidity of $752M (cash + undrawn facilities) was available.
- Operational and productivity gainsAPIP delivered $50M of recurring savings. Examples of operational gains: 66% reduction in lead time for TouchNTuff, HyFlex lead times cut by >90% by moving production closer to customers, and Kimtech supplier consolidation reduced lead time by >68%.
- Sustainability and safety progressWorkplace accidents reduced by 32% year-on-year. Renewable energy now represents 58% of sourced energy. Over 90% of packaging is recyclable, reusable, or compostable.
DE:PD1A Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 22, 2027 | 2027 (Q2) | 0.68- | 0.59 | ― | ― |
| Aug 23, 2026 | 2026 (Q4) | 0.690.73 | 0.63 | 16.43% (+0.10) | |
| Feb 15, 2026 | 2026 (Q2) | 0.570.59 | 0.5 | 19.03% (+0.09) | |
| Aug 24, 2025 | 2025 (Q4) | 0.600.63 | 0.55 | 13.09% (+0.07) | |
| Feb 09, 2025 | 2025 (Q2) | 0.500.50 | 0.37 | 35.52% (+0.13) | |
| Aug 19, 2024 | 2024 (Q4) | 0.480.55 | 0.57 | -3.28% (-0.02) | |
| Feb 19, 2024 | 2024 (Q2) | 0.360.37 | 0.45 | -18.77% (-0.09) | |
| Aug 13, 2023 | 2023 (Q4) | 0.580.57 | 0.7 | -17.95% (-0.13) | |
| Feb 13, 2023 | 2023 (Q2) | 0.500.45 | 0.54 | -16.50% (-0.09) | |
| Aug 22, 2022 | 2022 (Q4) | 0.600.70 | 0.96 | -27.44% (-0.26) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

